Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
CNS Pharmaceuticals, Inc. has filed 389 SEC EDGAR filings since 13 Mar 2018

SEC filing history

Showing 351-375 of 389 matching filings.

Per page
25
Current page
15
8-K File 001-39126

FORM 8-K

Filing date
13 Jan 2020
Reporting date
13 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

FORM 8-K

Filing date
22 Nov 2019
Reporting date
20 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
14 Nov 2019
Reporting date
13 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Nov 2019
Reporting date
13 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
13 Nov 2019
Reporting date
13 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
08 Nov 2019
Reporting date
07 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
08 Nov 2019
Reporting date
07 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
08 Nov 2019
Reporting date
07 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
08 Nov 2019
Reporting date
07 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
08 Nov 2019
Reporting date
07 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
08 Nov 2019
Reporting date
07 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-232443

PROSPECTUS

Filing date
08 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-232443

EFFECT filing

Filing date
07 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-39126

CERT filing

Filing date
06 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
05 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
05 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-39126

FORM 8-A

Filing date
05 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-232443

FREE WRITING PROSPECTUS

Filing date
15 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-232443

FWP

Filing date
10 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-232443

FORM S-1 AMENDMENT 3

Filing date
07 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-232443

FORM S-1 AMENDMENT 2

Filing date
22 Aug 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-232443

FREE WRITING PROSPECTUS

Filing date
16 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
16 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-232443

AMENDMENT NO. 1 TO FORM S-1

Filing date
16 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .